| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/16/2000 | EP0979816A1 Hydroxamic acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/16/2000 | EP0979814A1 Improved synthesis of haloformimine compounds |
| 02/16/2000 | EP0979654A1 Activated vitamin d 3? emulsion-type lotions |
| 02/16/2000 | EP0979653A1 Remedy for chronic fatigue syndrome |
| 02/16/2000 | EP0979652A1 Remedial composition for intraocular hypertension or glaucoma |
| 02/16/2000 | EP0979651A1 Portal hypertension inhibitor |
| 02/16/2000 | EP0979650A1 Antiviral agents |
| 02/16/2000 | EP0979648A2 Microspheres of esters of hyaluronic acid for controlled release of an active |
| 02/16/2000 | EP0979513A1 PROCESS AND APPARATUS FOR THE PRODUCTION OF Bi-212 AND A USE THEREOF |
| 02/16/2000 | EP0979311A1 $i(IN VIVO) USE OF RECOMBINAGENIC OLIGONUCLEOBASES TO CORRECT GENETIC LESIONS IN HEPATOCYTES |
| 02/16/2000 | EP0979309A1 Oligonucleotides for enhanced bioavailability |
| 02/16/2000 | EP0979292A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 02/16/2000 | EP0979286A2 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold |
| 02/16/2000 | EP0979273A1 MODIFIED ANTISENSE NUCLEOTIDES COMPLEMENTARY TO A SECTION OF THE HUMAN Ha-Ras GENE |
| 02/16/2000 | EP0979230A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
| 02/16/2000 | EP0979229A1 2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors |
| 02/16/2000 | EP0979228A1 Novel cannabinoid receptor agonists |
| 02/16/2000 | EP0979226A1 Isoxazole derivatives |
| 02/16/2000 | EP0979224A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate |
| 02/16/2000 | EP0979105A1 Topical nasal antiinflammatory compositions |
| 02/16/2000 | EP0979103A1 Compounds |
| 02/16/2000 | EP0979099A1 Use of lactoferin in the treatment of allergen induced disorders |
| 02/16/2000 | EP0979098A1 Method of treating hyperprolactinemia and prolactinomas |
| 02/16/2000 | EP0979096A1 Treatment of infarcts through inhibition of nf-kappab |
| 02/16/2000 | EP0979092A2 Allelic polygene diagnosis of reward deficiency syndrome and treatment |
| 02/16/2000 | EP0979091A1 Pourable alginate compositions |
| 02/16/2000 | EP0979090A1 Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine |
| 02/16/2000 | EP0979089A1 Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells |
| 02/16/2000 | EP0979087A1 Analgesic combination |
| 02/16/2000 | EP0979086A2 Method and composition for modulating amyloidosis |
| 02/16/2000 | EP0979085A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 02/16/2000 | EP0979084A1 Use of anabolic steroid derivatives in the treatment of chronic heart failure |
| 02/16/2000 | EP0979083A2 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions |
| 02/16/2000 | EP0979082A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
| 02/16/2000 | EP0979081A1 Composition and methods using an eutomer |
| 02/16/2000 | EP0979079A1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 02/16/2000 | EP0979078A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 02/16/2000 | EP0979077A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders |
| 02/16/2000 | EP0979074A1 Treatment or prevention of menopausal symptoms and osteoporosis |
| 02/16/2000 | EP0979073A1 Nitrosylation to inactivate apoptotic enzymes |
| 02/16/2000 | EP0979072A1 Transdermal device for the delivery of testosterone |
| 02/16/2000 | EP0979065A1 Use of oligosaccharides for the treatment of connective tissues |
| 02/16/2000 | EP0802900B1 Antiarrhythmic (s)-enantiomers of methanesulfonamides |
| 02/16/2000 | EP0642335B1 Controlled release preparation containing a salt of morphine |
| 02/16/2000 | CN1244872A Glucagon-like peptide-2 analogs |
| 02/16/2000 | CN1244870A Tissue specific expression of retinoblastoma protein |
| 02/16/2000 | CN1244869A Crystal form O of clarithromycin |
| 02/16/2000 | CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase |
| 02/16/2000 | CN1244866A Imino-aza-anthracyclinone derivatives for the treatment of amyloidosis |
| 02/16/2000 | CN1244864A 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
| 02/16/2000 | CN1244863A Novel benzopyran derivatives |
| 02/16/2000 | CN1244862A Endothelin antagonists: N-[[2'-[[4,5-dimethyl-3-isoxazolyl) amino] sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl] methyl] |
| 02/16/2000 | CN1244859A Benzenesulfonamide derivatives and drugs containing the same |
| 02/16/2000 | CN1244806A Compositions for transdermal administration of streoid drugs |
| 02/16/2000 | CN1244805A Stable lyophilized pharmaceutical substance from monoclonal or polyclonal antibodies |
| 02/16/2000 | CN1244801A Sulfonylurea-glitazone synergistic combinations for diabetes |
| 02/16/2000 | CN1244800A Remedy for axillary osmidrosis containing adrenocorticosteriodal preparation |
| 02/16/2000 | CN1244799A L-beta-dioxolane uridine analogs and method for treating and preventing virus infections |
| 02/16/2000 | CN1244798A Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds |
| 02/16/2000 | CN1244797A Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 02/16/2000 | CN1244796A Pellets having a core coated with an antifungal and a polymer |
| 02/16/2000 | CN1244535A Preparation of Fenbijie general glycoside as a new anticarcinogen |
| 02/16/2000 | CN1244533A Zinc scutellarin as a new medicine |
| 02/16/2000 | CN1244532A 3,6-aldehyde acetal and enol ether large ring lactone vitamine |
| 02/16/2000 | CN1244529A Novel 8H-thiophene [2,3-b] pyrrolinezine-8-on compound, its preparing method and their medicinal compounds containing them |
| 02/16/2000 | CN1244528A Di- Or triaza-spiral [4,5] decane derivative |
| 02/16/2000 | CN1244526A Effective synthetic method for furau sulfonic acid amide compound for synthesizing new IL-1 inhibitor |
| 02/16/2000 | CN1244525A Substituted dihydropyridine dicarboxylic ester |
| 02/16/2000 | CN1244523A Extraction and purification of tetracyclic antibiotics with alcohol solvents |
| 02/16/2000 | CN1244428A Fast-acting burn and scald treating liquid |
| 02/16/2000 | CN1244422A Pain relieving ointment and its preparation |
| 02/16/2000 | CN1244419A Naojinzhi oral liquor and its preparation |
| 02/16/2000 | CN1244416A 复方咽炎胶囊 Compound pharyngitis Capsules |
| 02/16/2000 | CN1244410A Chinese medicine for treating piles and its preparation |
| 02/16/2000 | CN1244394A Oral preparation with Dimethoate detoxicating function |
| 02/16/2000 | CN1244393A Gastritis treating tablet |
| 02/16/2000 | CN1244392A Externally used medicine for treating tinea |
| 02/16/2000 | CN1244391A Long-acting analgesic used mainly for operational cut and traumatic wound |
| 02/16/2000 | CN1244390A Medical metronidazole toothpaste |
| 02/16/2000 | CN1244389A Elemi olefine injecta and its preparation |
| 02/16/2000 | CN1049434C Aromatic amidine derivatives and method for preparing medicinal salts thereof |
| 02/16/2000 | CN1049433C 6,7-modified paclitaxels and medicinal composition containing said compound |
| 02/16/2000 | CN1049431C Morpholine derivative and its use and medicinal prepration containing said derivatives |
| 02/16/2000 | CN1049430C Sulfonamides and its preparing method and use thereof |
| 02/16/2000 | CN1049428C Short-acting dihydropyridines compounds and its preparing method and use |
| 02/16/2000 | CN1049423C 芳香羧酸衍生物 Aromatic carboxylic acid derivatives |
| 02/16/2000 | CN1049358C Eye drops containing vinyl carboxylate polymer and its producing method |
| 02/16/2000 | CN1049357C Treatment of human viral infection by ds RNA combined with viral inhibitors |
| 02/16/2000 | CN1049344C Nutrient health-care oral liquor containing bee larva nutritive composition |
| 02/16/2000 | CN1049337C Concentrated aqueous solution of rotary enzyme inhibitor |
| 02/16/2000 | CN1049336C Isoxazole derivatives for the treatment of irritable bowels system in preparing composition |
| 02/16/2000 | CN1049335C Medicinal use of benzothiophene compounds |
| 02/16/2000 | CN1049334C New use of fatty acid medicine |
| 02/16/2000 | CN1049333C Process for producing fine particulate materials |
| 02/15/2000 | USRE36575 Pyridine and thiazolidinedione derivatives |
| 02/15/2000 | US6025511 A myristic acid selected analogs for inhibiting the biosynthesis of the glycosyl phosphatidylinositol (gpi) anchor of the parasite |
| 02/15/2000 | US6025507 Borneol derivatives, methods of manufacturing them, and their pharmaceutical use |
| 02/15/2000 | US6025494 Tetracyclic derivatives, process of preparation and use |
| 02/15/2000 | US6025493 For treatment of psychological disorders, alzheimer's disease, parkinson's disease, nervous system disorders |
| 02/15/2000 | US6025488 Formulations and methods of reducing toxicity of antineoplastic agents |